Navigating PFAS Laws Under the New Administration: What to Watch

December 31, 2024

Reading Time : 1 min

By: David H. Quigley, Shivani Swami (International Law Advisor)

As we turn to 2025 and a new administration, there are a few areas of per- and polyfluoroalkyl substances (PFAS) law worth watching in the short term, including the regulation of the chemicals in water and their treatment under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). Following the lawsuit filed earlier this year by water utilities and chemical companies challenging the Environmental Protection Agency’s (EPA) rule setting maximum contaminant levels (MCLs) for six PFAS in drinking water, it will be interesting to see how the new administration supports (if at all) EPA’s recent response contradicting the allegations of an unlawful and inadequate cost benefit analysis, procedural omissions in the rulemaking process and use of out-of-date science. Michael Dourson, a toxicologist that President-elect Trump reportedly considered to be head of EPA’s toxics office during his first term, may have the ear of Trump 2.0 and is publishing a series of articles questioning the process by which the Biden administration set its MCLs. On the CERCLA side, industry groups have also written to President-elect Trump encouraging “an incremental approach to PFAS” that prioritizes regulation of “higher-risk PFAS” over polymerized PFAS (fluoropolymers) and criticizing as onerous (in addition to the MCLs) rules designating PFOA and PFOS as hazardous substances under that law (which also is subject to challenge in federal court).

Share This Insight

Previous Entries

PFAS Press

April 10, 2026

On April 9, 2026, the Environmental Protection Agency (EPA) announced a long-anticipated delay in the reporting window for the per- and polyfluoroalkyl substances (PFAS) reporting rule under the Toxic Substances Control Act (TSCA). In October 2023, EPA imposed a one-time requirement under TSCA on entities that manufactured (including imported) PFAS or PFAS containing products between 2011 and 2022 to submit to EPA information regarding PFAS exposure and environmental and health effects. After two extensions due to delays in developing the web-based reporting portal, the reporting window under the rule was set to open on April 13, 2026, and close on October 13, 2026. As the opening date approached, EPA proposed a partial rollback of the rule that would both exempt certain categories of PFAS from the reporting requirements and change the reporting period (a prior PFAS Press blog post discusses the proposed rollback) but until today it had not formally cancelled the original start date. With the announcement, EPA resolved the uncertainty, confirming that reporting will not commence on April 13 and instead will begin only 60 days after the revised rule becomes effective (although questions still remain as to whether EPA will shorten the reporting window from the original six months to the proposed three months). EPA plans to issue a final rule on reporting later this year, with updated guidance and reporting tools accompanying the revised requirements.

...

Read More

PFAS Press

February 17, 2026

We have previously discussed here the somewhat groundbreaking approach (in the U.S. anyway) taken by New Mexico’s Per- and Polyfluoroalkyl Substances (PFAS) Protection Act, enacted in March 2025, which included a first of its kind exemption for fluoropolymers from the law’s sales bans on PFAS-containing products. Subsequent regulatory actions in the state proposed excluding certain federally-regulated (and fluoropolymer-containing) products, including U.S. Food and Drug Administration (FDA) regulated medical devices, from the scope of labeling requirements. The New Mexico Environmental Improvement Board (EIB) currently is accepting public input on those proposed labeling rules, with public testimony scheduled to begin February 23 and written comments due by March 31. After recent legislative moves, it appears that participation in this comment period may be of the utmost importance to the regulated community. On February 5, 2026, the House Energy, Environment and Natural Resources Committee recommended passage of House Joint Memorial 3, which alleges a “limited scientific literature” supporting the above moves to exempt fluoropolymers and requests that the New Mexico Environment Department prepare a report evaluating implementation of the PFAS Protection Act, including the effectiveness of EIB’s rules and assessing the health, environmental and economic implications of statutory and regulatory exemptions, and provide recommendations on whether exemptions such as the fluoropolymer carve out should be maintained, revised or eliminated. Manufacturers seeking to maintain the exemptions will want to use the comment period to support doing so.

...

Read More

PFAS Press

January 22, 2026

Akin environment & natural resources practice head David Quigley is quoted by Chemical Watch news & events by Enhesa in the third part of its 2026 Global Outlook series titled, “What’s next for state-level chemicals policy in the US in 2026?” discussing his expectations for state-level chemical policy trends in 2026 and the outlook for regulation and enforcement especially as it relates to PFAS.

...

Read More

PFAS Press

January 20, 2026

To ring in the new year, New Jersey became the latest state to enact legislation banning intentionally-added PFAS in certain consumer products. In the final days of his term, Governor Murphy signed into law the Protecting Against Forever Chemicals Act (S 1042), which prohibits the sale of cosmetics, carpets, fabric treatments and food packaging containing intentionally-added PFAS starting in January 2028. The law also requires manufacturers to label certain direct food contact consumer cookware that contains intentionally-added PFAS. Interestingly, the legislature stripped forward-looking provisions excluding fluoropolymers just prior to passage. Definitely an area to watch as additional states dip their feet in the PFAS pool in 2026.  

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.